Test validation and availability

IndiTreat^® is ready for your patients today

IndiTreat^® Colorectal Cancer Sensitivity Test is a CE IVD validated test available throughout the EU and the UK.

IndiTreat^® tests are performed at 2cureX laboratories in Europe. We can perform tests on your patients and can compare to results from reference patients.

Drug sensitivity testing on patient-derived 3D microtumors can provide vital information for every individual patient, and improve the likelihood of success of cancer treatment. IndiTreat^® is a useful complement to the advances achieved in individual patient genomic characterization of tumors.

Improving the likelihood of success of cancer treatment

2cureX, pioneers in the use of 3D microtumors in cancer therapy, are empowering oncologists to select treatments more efficiently and thereby improve treatment outcomes.